Okava Pharmaceuticals

Curated by Signal

Developer of pharmaceuticals for animals

Overview

Developer of pharmaceuticals for animals. The company leverages proprietary technologies and develops drugs for dogs and cats. The product pipeline includes OKV-1001 for hemolytic anemia, and arthritis, and OKV-199 for diabetes and heart diseases.

Key facts

Founded: 2015
Headquarters: San Francisco, United States
Stage: Sign up to view
Industry: Health Technology

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Meld
AI-powered software to accelerate clinical trials
Health TechnologyNew York, United States
Heroes Health
Provider of a platform for healthcare workers to track their mental health
Health TechnologyChapel Hill, United States
BATCH
Provider of cannabis-based health and wellness products
Health TechnologyMilwaukee, United States

About Okava Pharmaceuticals

What does Okava Pharmaceuticals do?

Developer of pharmaceuticals for animals.

Where is Okava Pharmaceuticals headquartered?

Okava Pharmaceuticals is headquartered in San Francisco, United States.

When was Okava Pharmaceuticals founded?

Okava Pharmaceuticals was founded in 2015.

Which sector is Okava Pharmaceuticals in?

Okava Pharmaceuticals operates in Health Technology.

Who are Okava Pharmaceuticals's competitors?

Companies similar to Okava Pharmaceuticals include Meld, Heroes Health, and BATCH.